Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-6988|3|2|131-137

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.3, Iss.2, 2016-10, pp. : 131-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 131-137

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012

By Dymock Brian W   See Cheng Shang  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 449-501

Informa Healthcare

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1767-1784

Bentham Science Publishers

Access to resources Recommend Favorite

Imatinib: Emergence of JAK2V617F clone leading to polycythaemia vera, in an elderly patient?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite